Chin J Schisto Control ›› 2017, Vol. 29 ›› Issue (4): 530-533.

Previous Articles     Next Articles

Progress in researches of benzimidazole in treatment of echinococcosis

ZHU Wen-jun|HAN Xiu-min|GUO Ya-min*   

  1. Graduate School of Qinghai University|Xining 810000|China
  • Online:2017-08-28 Published:2017-08-28
  • Contact: GUO Ya?min

苯并咪唑类药物治疗包虫病研究进展

朱文君|韩秀敏|郭亚民*   

  1. 青海大学研究生院(西宁810000)
  • 通讯作者: 郭亚民
  • 作者简介:朱文君|男|硕士研究生。研究方向:包虫病治疗方式及预后
  • 基金资助:
    青海省科技国际合作计划项目(2015?HZ?809)

Abstract: Echinococcosis is a severe zoonosis parasitic disease and mainly caused by the larvae of Echinococcus granulosus and E. multilocularis. Because of the limitation of operation level,such as recurrence and death,the drug treatment is still the most important method in our country. Meanwhile,the annual number of drug treatments is far greater than surgical treatments. Drugs play a significant role in the preoperative reduction of lesions,reducing pain,extending the life of patients .This article re? views the status of animals treatment and clinical treatment of echinococcosis treated by the benzimidazole drugs and their new formulations,provides the basis for exploring the development direction of anti?echinococcosis drug treatment research.

Key words: Echinococcosis;Benzimidazole;Chemotherapy

摘要: 包虫病主要是由细粒棘球绦虫和多房棘球绦虫的幼虫引起的严重的人兽共患寄生虫病。在我国,由于受手术 复发、死亡等手术水平的限制,药物治疗仍然是目前最主要的治疗方法,每年药物治疗的数量远大于手术治疗数。药物 在术前缩小病灶、减轻痛苦,延长患者寿命发挥着重要作用。本文综述苯并咪唑类药物及其新剂型的动物及临床治疗包 虫病现况,为探索包虫病药物治疗研究的发展方向提供依据。

关键词: 包虫病;苯并咪唑类;药物治疗

CLC Number: